| Product NDC: | 68047-157 |
| Proprietary Name: | ExeFen IR |
| Non Proprietary Name: | Guaifenesin and Pseudoephedrine Hydrochloride |
| Active Ingredient(s): | 400; 60 mg/1; mg/1 & nbsp; Guaifenesin and Pseudoephedrine Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 68047-157 |
| Labeler Name: | Larken Laboratories, Inc. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part341 |
| Marketing Category: | OTC MONOGRAPH FINAL |
| Start Marketing Date: | 20110110 |
| Package NDC: | 68047-157-01 |
| Package Description: | 100 TABLET in 1 BOTTLE (68047-157-01) |
| NDC Code | 68047-157-01 |
| Proprietary Name | ExeFen IR |
| Package Description | 100 TABLET in 1 BOTTLE (68047-157-01) |
| Product NDC | 68047-157 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Guaifenesin and Pseudoephedrine Hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20110110 |
| Marketing Category Name | OTC MONOGRAPH FINAL |
| Labeler Name | Larken Laboratories, Inc. |
| Substance Name | GUAIFENESIN; PSEUDOEPHEDRINE HYDROCHLORIDE |
| Strength Number | 400; 60 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes |